Loading...
BAYER logo

Bayer AktiengesellschaftBUSE:BAYER Stock Report

Market Cap Ft17.5t
Share Price
n/a
1Y59.0%
7D0%
1D-1.2%
Portfolio Value
​
View

Bayer Aktiengesellschaft

BUSE:BAYER Stock Report

Market Cap: Ft17.5t

Bayer (BAYER) Stock Overview

Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. More details

BAYER fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Rewards

Trading at 60.3% below our estimate of its fair value

Earnings are forecast to grow 41.28% per year

Risk Analysis

Volatile share price over the past 3 months compared to the Hungarian market


BAYER Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

NEW483,745 members

Join community and earn perks

Gain real feedbackFrom our editorial team, personally. Not silence.
Grow your followingReal investors. The kind who actually invest, not scroll past.
Unlock free accessFree premium subscription for consistent and quality authors.
Learn moreCreate Narrative
BL
BlackGoat
IN
Investingwilly
RO
RockeTeller
DA
davidlsander
483,745 investors already sharing narratives
View all narratives

Bayer Aktiengesellschaft Competitors

Price History & Performance

Summary of share price highs, lows and changes for Bayer
Historical stock prices
Current Share Price€17,685.00
52 Week High€18,890.00
52 Week Low€10,100.00
Beta0.83
1 Month Change1.90%
3 Month Change25.65%
1 Year Change59.04%
3 Year Change-7.86%
5 Year Change6.34%
Change since IPO10.64%

Recent News & Updates

Recent updates

Shareholder Returns

BAYERHU PharmaceuticalsHU Market
7D0%-1.1%-1.0%
1Y59.0%13.7%28.2%

Return vs Industry: BAYER exceeded the Hungarian Pharmaceuticals industry which returned 13.7% over the past year.

Return vs Market: BAYER exceeded the Hungarian Market which returned 28.2% over the past year.

Price Volatility

Is BAYER's price volatile compared to industry and market?
BAYER volatility
BAYER Average Weekly Movement8.2%
Pharmaceuticals Industry Average Movement4.8%
Market Average Movement5.0%
10% most volatile stocks in HU Market8.8%
10% least volatile stocks in HU Market3.0%

Stable Share Price: BAYER's share price has been volatile over the past 3 months compared to the Hungarian market.

Volatility Over Time: BAYER's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Hungarian stocks.

About the Company

FoundedEmployeesCEOWebsite
186387,830Bill Andersonwww.bayer.com

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy.

Bayer Aktiengesellschaft Fundamentals Summary

How do Bayer's earnings and revenue compare to its market cap?
BAYER fundamental statistics
Market capFt17.50t
Earnings (TTM)-Ft635.02b
Revenue (TTM)Ft16.58t
1.1x
P/S Ratio
-27.6x
P/E Ratio

Is BAYER overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BAYER income statement (TTM)
Revenue€45.38b
Cost of Revenue€17.94b
Gross Profit€27.43b
Other Expenses€29.17b
Earnings-€1.74b

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

Nov 03, 2026

Earnings per share (EPS)-1.77
Gross Margin60.46%
Net Profit Margin-3.83%
Debt/Equity Ratio124.8%

How did BAYER perform over the long term?

See historical performance and comparison

Dividends

0.2%
Current Dividend Yield
-6%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/19 20:44
End of Day Share Price 2026/08/12 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Bayer Aktiengesellschaft is covered by 40 analysts. 17 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Rafael Bonardell TrianesBanco de Sabadell. S.A.
Emily FieldBarclays
Charles PitmanBarclays